STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ:APDN), has signed a new CertainT® trademark license agreement with Palmetto Synthetics (“Palmetto”), a leader in the production of high quality, specialty synthetic fiber. Palmetto’s mission “is to be the leading global innovator and provider of specialty synthetic fiber while fostering a culture of integrity, dignity and respect for their team members, business partner, community and environment.” The newly signed CertainT trademark licensing agreement enables Palmetto to reach their goals of bringing transparency to their own manufacturing processes, and also to provide their customers with traceability and trust in the original tagged synthetic fiber.
Under the CertainT® platform, customers are provided with secure, forensic guidelines for monitoring the flow of product through the manufacturing process via molecular tagging, testing and tracking. Routine inspection and authentication is transparent and certified throughout the process via an integrated database and portal. CertainT also helps customers with meeting their sustainability goals by 2020. Products that use recycled, renewable or re-usable materials that have an eco-conscious composition can benefit from molecular tagging.
David Poston, President of Palmetto Synthetics stated “that to continue to be an industry leader, one must embrace new technology in paving the way to commit to customer excellence through the promotion of state of the art technology. As indicated in the past, we have our eye on the future and we are excited about CertainT’s platform and look forward to total implementation.”
“The CertainT system physically traces the raw material, ingredient, component and product, so you can claim that you are performing full traceability from source to shelf. That’s the difference between most standards that certify products that use a paper trail, or a mass-balance approach, where certified raw materials, such as recycled PET can be easily mixed with non-certified ones. CertainT can help assure product integrity and traceability by ensuring the product itself,” stated Dr. James A. Hayward, President and CEO of Applied DNA Sciences.
Applied DNA Sciences and Palmetto Synthetics will be co-presenting with Techmer PM at the Synthetic Yarn Fibers Association Fall Conference in Charlotte, North Carolina in October 27, 2017.
About Palmetto Synthetics
Palmetto Synthetics, headquartered in Kingstree, SC, is a provider of custom design solutions in the world of synthetic fiber. They offer a wide range of polymers that can be spun into fiber for such end uses as footwear, performance apparel, geotextiles fabrics for erosion control, roofing products and filtration media. They also are heavily engaged in post-consumer recycled fibers for a variety of applications.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.
We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based "CertainT®" platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.
SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature®T and fiberTyping®, targeted towards textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017 which are available at www.sec.gov. APDN , undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.